Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy

Recruiting now · Not applicable

Conditions studied: Dexmedetomidine, Lidocaine, Infusion, Adjuvants, General Anesthesia, Chronic Pain, Mastectomy

In brief

This study aims to compare dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia for chronic pain management after mastectomy.

Key facts

Study ID

NCT06910644

Run by

Cairo University

People needed

90

Starts

2025-04-05

Expected to finish

2025-12-01

Last updated by the study team

2025-04-08

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age from 18 to 75 years.
• American Society of Anesthesiologists (ASA) physical status II.
• Scheduled for mastectomy with axillary dissection (either modified radical mastectomy with or without latissimus dorsi flap or conservative breast surgery) due to breast cancer.

You may not qualify if…

• Patient refusal.
• Known allergy to any of the study drugs.
• Those with hepatic or renal insufficiency.
• Patients who are running regularly on B blockers.
• α2 adrenergic agonists and sedatives.
• Psychoactive medications.

Where it is running

• Cairo University — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.